Children exposed to SARS-CoV-2 who developed Multisystemic Inflammatory Syndrome (MIS-C) present with specific retinal microvascular changes, a study shows.
During omicron predominance, the estimated vaccine effectiveness (VE) of the BNT162b2 two-dose vaccination among children and adolescents was modest and decreased rapidly.
Researchers suspect patients with neurofibromatosis type 1 experience a dysregulation of melanocytogenesis, inducing abnormal polarization on both sides of RPE.
Only 18% of parents of children younger than 5 years say they plan to get their child vaccinated against COVID-19 as soon as they can, while nearly four in 10 say they will “wait and see” before getting shots for their child.
Edmund Tsui, MD, social media editor for the American Academy of Ophthalmology’s journal Ophthalmology, guides readers through what’s trend-worthy in eye care.
Moderna announced that it has asked the US Food and Drug Administration to authorize the emergency use of its COVID-19 vaccine for children younger than 6 years old.
Pfizer Inc. announced that it has asked the US Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.
Axial length, lens thickness, and mean keratometry are the primary structural metrics associated with macular thickness, but living place and other demographic factors also play a role.
During the period of omicron predominance, COVID-19-associated hospitalization among children aged 5 to 11 years, including among those with no underlying health conditions, was increased.